GLS and experimental autoimmune encephalomyelitis: The glutaminase antagonist JHU083, a prodrug of DON, has been reported to be a potential anti-inflammatory modulator to reverse experimental autoimmune encephalomyelitis through inhibiting T cells proliferation and activation (46).